BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚น143.56 B
Marketcap
โ‚น681.86
Share price
-3.07%
Change (1 day)
5.83%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น19.12 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has โ‚น19.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น27.52 B-15%
2023-12-31โ‚น32.38 B-7.77%
2022-12-31โ‚น35.11 B-7.07%
2021-12-31โ‚น37.78 B71.99%
2020-12-31โ‚น21.96 B126.13%
2019-12-31โ‚น9.71 B32.99%
2018-12-31โ‚น7.30 B0%
2017-12-31โ‚น7.30 B96.68%
2016-12-31โ‚น3.71 B8.38%
2015-12-31โ‚น3.42 B-25.7%
2014-12-31โ‚น4.61 B96.17%
2013-12-31โ‚น2.35 B20.62%
2012-12-31โ‚น1.94 B-11.68%
2011-12-31โ‚น2.20 B-8.7%
2010-12-31โ‚น2.41 B-24.46%
2009-12-31โ‚น3.19 B8.2%
2008-12-31โ‚น2.95 B48.64%
2007-12-31โ‚น1.98 B19.93%
2006-12-31โ‚น1.65 B-26.65%
2005-12-31โ‚น2.26 B125.36%
2004-12-31โ‚น1.00 B10.06%
2003-12-31โ‚น0.91 B-22.22%
2002-12-31โ‚น1.17 B-24.04%
2001-12-31โ‚น1.54 B34.24%
2000-12-31โ‚น1.14 B14.49%
1999-12-31โ‚น1.00 B92.01%
1998-12-31โ‚น0.52 B250.2%
1997-12-31โ‚น0.14 B15.39%
1996-12-31โ‚น0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
โ‚น67.26 B 251.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น76.45 B 299.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.14 B-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น68.53 B 258.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น660.20 B 3,352.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น52.39 B 173.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.26 B 1,987.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น22.05 B 15.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น0.16 B-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA